Company Filing History:
Years Active: 2003
Title: Iwao Nozawa: Innovator in Polypeptide Research
Introduction
Iwao Nozawa is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of integrin-associated diseases through his innovative research and patent work. His expertise in polypeptide development has opened new avenues for therapeutic interventions.
Latest Patents
Iwao Nozawa holds a patent for a D-form polypeptide that inhibits the interaction between LFA-1 and ICAM-1. This patent outlines methods and compositions that are useful in inhibiting integrin-associated diseases. The compositions include polypeptides containing one or more D-amino acids that effectively inhibit integrin binding to its associated binding polypeptide. Notably, the compositions also encompass retro-inverso polypeptides.
Career Highlights
Iwao Nozawa is affiliated with the University of Kansas Medical Center Research Institute, where he continues to advance his research in the field of polypeptides. His work has garnered attention for its potential applications in treating various diseases linked to integrin interactions.
Collaborations
Iwao Nozawa has collaborated with esteemed colleagues such as Stephen H. Benedict and Marcia A. Chan. These partnerships have contributed to the depth and breadth of his research endeavors.
Conclusion
Iwao Nozawa's innovative work in polypeptide research exemplifies the impact of scientific inquiry on healthcare solutions. His contributions are paving the way for advancements in the treatment of integrin-associated diseases.